Status:
COMPLETED
Special Drug Use Investigation for ARIXTRA® (Fondaparinux) Injection
Lead Sponsor:
GlaxoSmithKline
Conditions:
Thromboembolism
Eligibility:
All Genders
Brief Summary
This post-marketing surveillance study was designed to collect and assess the information on proper use of fondaparinux injection, such as the safety and efficacy under actual use conditions, in subje...
Eligibility Criteria
Inclusion
- Subjects undergo orthopedic surgery of the lower limb at high risk of developing venous thromboembolism
Exclusion
- Not applicable
Key Trial Info
Start Date :
September 1 2007
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 1 2009
Estimated Enrollment :
1280 Patients enrolled
Trial Details
Trial ID
NCT01420809
Start Date
September 1 2007
End Date
August 1 2009
Last Update
May 16 2017
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.